LyphoMed Inc said it and VestarInc entered into a joint venture to develop and market liposomeformulations of selected drugs.    Liposomes are spheres of subcellular size which arecomposed of phospholipids, the primary components of livingcell membranes.    During the project's first year, the companies will jointlydevelop liposome formulations for designated drugs andestablish a commercial production capacity as well ascoordinate and fund clinical studies of the formulations. Reuter&#3;